Cargando…
Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
BACKGROUND: Intra-tumor heterogeneity (ITH) plays a vital role in drug resistance and recurrence of lung cancer. We used a mutant-allele tumor heterogeneity (MATH) algorithm to assess ITH and investigated its association with clinical and molecular features in advanced lung adenocarcinoma. METHODS:...
Autores principales: | Wu, Xiaoxuan, Song, Peng, Guo, Lei, Ying, Jianming, Li, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286753/ https://www.ncbi.nlm.nih.gov/pubmed/35847947 http://dx.doi.org/10.3389/fonc.2022.888951 |
Ejemplares similares
-
Integration of the Tumor Mutational Burden and Tumor Heterogeneity Identify an Immunological Subtype of Melanoma With Favorable Survival
por: Gao, Yanmei, et al.
Publicado: (2020) -
Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patients
por: Wu, Hua-Jun, et al.
Publicado: (2022) -
Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020) -
Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
por: Han, Yuying, et al.
Publicado: (2020) -
Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index
por: Hu, Nan, et al.
Publicado: (2021)